Blockade of the sonic hedgehog signalling pathway inhibits choroidal neovascularization in a laser-induced rat model

Abstract

Sonic hedgehog (Shh) signaling has recently been shown to be involved in the pathological angiogenesis in response to tissue hypoxia and ischemic injury. Hypoxia/ischemia is considered to play an important role in the development of choroidal neovascularization (CNV). This study was aimed to examine the effect of blockade of the Shh signaling pathway on CNV and the underlying mechanism. A total of 64 male Brown-Norway (BN) rats were used in this study. One eye of each rat underwent laser photocoagulation. The other eye served as normal control. After the laser treatment, the 64 rats were divided into four groups (n=16 in each group): Blank control group, in which no intravitreal administration was given; cyclopamine group, recombinant Shh N-terminals protein (rShh) group and phosphate-buffered saline (PBS) group, in which cyclopamine (a Shh inhibitor), rShh (a Shh activator) and PBS were intravitreally injected into the laser-treated eyes respectively every other day for a total of four intravitreal injections immediately after the laser treatment. Fourteen days after the intravitreal administration, the changes of CNV-related variables, including positive CNV lesion percentage, CNV membrane area and CNV membrane thickness, were evaluated by fluorescein angiography, indocyanine green angiography and pathological examinations. The mRNA and protein expression of PTCH1, Gli1, HIF-1(α), VEGF and DLL4 in each group on 14 days of CNV model was detected by real-time quantitative PCR and western blot analysis, and the relationship between the Shh cascade and the HIF-1(α)-VEGF-DLL4 cascade in CNV was analyzed. The results showed that the CNV membrane area and the CNV membrane thickness were decreased by 62.5% and 41.9% in the cyclopamine group and increased by 85.7% and 64.3% in the rShh group in comparison to those in the blank control group (P<0.01 for each). There was no significant difference in the CNV membrane area and thickness between the blank control group and PBS group (P=0.102 and P=0.063, respectively). Real-time quantitative PCR revealed a 5.23-, 4.14-, 2.97-, 2.78- and 2.39-fold up-regulation of the mRNA expression of PTCH1, Gli1, HIF-1(α), VEGF and DLL4 genes in the laser-treated eyes compared with the normal control eyes in the control group. In the cyclopamine group, the mRNA and protein expression of Gli1, HIF-1(α), VEGF and DLL4 was significantly down-regulated (P<0.05 for each) while the expression of PTCH1 showed no significant changes at the mRNA (P=0.293) and protein level (P=0.304). The mRNA expression and protein expression (P=0.001 and P=0.021, respectively) of PTCH1, Gli1, HIF-1(α), VEGF and DLL4 was significantly increased in the rShh group when compared with the control group. The expression level of these genes was related to the severity of the CNV. It was concluded that intravitreal administration of cyclopamine can effectively inhibit the formation of laser-induced experimental CNV by down-regulating the expression of the HIF-1(α)-VEGF-DLL4 cascade in CNV. The Shh signaling pathway as an ...

Nuclear Factor Kappa-B Signaling Is Integral to Ocular Neovascularization in Ischemia-Independent Microenvironment

“…We have utilized the intravitreal administration of YC-1 as a method of drug delivery, because this route delivers the drug in close proximity to the localization of the pathology, while the vitreous serves as a drug reservoir, which keeps the drug longer at the site. In addition, the sextuple injection regimen, which implemented in this study, was used to maximize chances of success for proof of concept, but is not ideal for clinical application, despite that implementing the same modality (multiple intravitreal injections) have been previously reported in various investigations [37] , [38] , [39] , [40] , [41] . The selection criterion of sextuple injection regimen was based on the standards, which we have established throughout our previous studies.…”

Role of Hedgehog Signaling in Vasculature Development, Differentiation, and Maintenance

“…This is associated with increased Gli1 and Vegfa expression levels [103]. In addition, Shh and Ptch1 are overexpressed in the eye both in retinopathy of prematurity (ROP) [47] and in laser-induced choroidal neovascularization [47,104], promoting pathological angiogenesis; inhibition of the Hh pathway (Cyclopamine) results in reduced angiogenesis and decreased Vegfa and Ptch1 levels, placing Shh activation upstream of Vegfa in experimental retinal angiogenesis [47]. Moreover, in mice with chronic liver injury or mice that underwent acute partial hepatectomy, administration of a Smo antagonist (GDC-0449 or Cyclopamine) prevents liver sinusoidal EC capillarization [105], and a study suggests that Annexin a2 may promote EC proliferation and angiogenesis by increasing Ihh and Gli1 in the setting of rheumatoid arthritis [106].…”

The RNA m5C methylase NSUN4 protects retinal ganglion cells by regulating m5C methylation in the Hedgehog signaling pathway

“…SHH signaling has recently been shown to be involved in pathological angiogenesis in response to tissue hypoxia and ischemic injury. It was concluded that the SHH inhibitor cyclopamine can effectively inhibit the development of laser-induced experimental choroidal neovascularization 59 . In addition, whole-exome sequencing and Sanger sequencing con rmed that Shh was differentially expressed and was one of the potential pathogenic mutations in peripheral venous blood samples of glaucoma patients compared with those of the ethnicity-matched normal control group.…”